Compare GRFS & SYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | SYM |
|---|---|---|
| Founded | 1940 | 2005 |
| Country | Spain | United States |
| Employees | 23800 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.5B |
| IPO Year | N/A | 2021 |
| Metric | GRFS | SYM |
|---|---|---|
| Price | $8.71 | $54.34 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 14 |
| Target Price | $10.15 | ★ $55.36 |
| AVG Volume (30 Days) | 608.0K | ★ 1.8M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $2,246,922,000.00 |
| Revenue This Year | $5.33 | $24.66 |
| Revenue Next Year | $6.50 | $27.88 |
| P/E Ratio | ★ $18.67 | $2,644.75 |
| Revenue Growth | N/A | ★ 25.65 |
| 52 Week Low | $6.19 | $16.32 |
| 52 Week High | $11.14 | $87.88 |
| Indicator | GRFS | SYM |
|---|---|---|
| Relative Strength Index (RSI) | 39.04 | 44.18 |
| Support Level | $8.66 | $48.60 |
| Resistance Level | $9.11 | $63.57 |
| Average True Range (ATR) | 0.27 | 2.72 |
| MACD | -0.08 | 0.05 |
| Stochastic Oscillator | 27.18 | 44.42 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.